From Our Partners
Tuesday, July 5, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Antimicrobial Resistance

Superbugs & Superdrugs Comes to the U.S.

by Global Biodefense Staff
July 7, 2016
Superbugs & Superdrugs USA

SMi Group’s respected antimicrobial event will travel to the United States this fall for the first Superbugs & Superdrugs USA on 14th and 15th November 2016.

The program will look to address key issues surrounding funding opportunities and U.S. national plans, multi resistance gram negative infections, novel protein based biologics, antimicrobial drug development and more.

Confirmed speakers to date include:

  • Christopher Houchens, Branch Chief, Antibacterial’s Program, BARDA
  • Rosemarie Aurigemma, Chief, Biodefense Drug Development Section, NIH
  • Anthony Simon Lynch, Senior Scientific Director, Janssen Research & Development LLC
  • Alita Miller, Director of Biology, Entasis Therapeutics
  • William J Weiss, Director, Pre-Clinical Services, UNT Health Science Center
  • Domingo Gargallo-Viola, Co-Founder and CSO, ABAC Therapeutics
  • David Cook, Chief Scientific Officer, Blueberry Therapeutics Ltd

This decision to enter the U.S. market follows the show’s 18 years and sell-out success in Europe with an audience a quarter of the audience traveling from the States.

For those who are interested, there is currently a $400 early bird discount available online which expires on July 15th. Further information is available at www.superbugs-usa.com.

Global Biodefense is an official media partner of Superbugs & Superdrugs USA 2016.

From Our Partners
Tags: AntimicrobialsASPRBARDAEventsHHSMRSA

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America
Infectious Diseases

Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America

June 10, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Load More

Latest News

Biodefense Headlines – 5 July 2022

Biodefense Headlines – 5 July 2022

July 5, 2022
Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC